Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

 837.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,764.00
  • 52 Week Low: 576.50
  • Currency: UK Pounds
  • Shares Issued: 126.53m
  • Volume: 0
  • Market Cap: £1,059.03m
  • RiskGrade: 314
  • Beta: 1.53

Tips & Analysis

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Indivior Market Data

Currency UK Pounds
Share Price 837.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,764.00
52 Week Low 576.50
Volume 0
Shares Issued 126.53m
Market Cap £1,059.03m
Beta 1.53
RiskGrade 314

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
56.93% below the market average56.93% below the market average56.93% below the market average56.93% below the market average56.93% below the market average
16% below the sector average16% below the sector average16% below the sector average16% below the sector average16% below the sector average
Price Trend
66.02% above the market average66.02% above the market average66.02% above the market average66.02% above the market average66.02% above the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Income Not Available
Growth
54.56% above the market average54.56% above the market average54.56% above the market average54.56% above the market average54.56% above the market average
Sector averageSector averageSector averageSector averageSector average

What The Brokers Say

Strong Buy 2
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Indivior Key Personnel

CEO Mark Crossley
Chair Graham Hetherington

Top of Page